Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction(Front. Cardiovasc. Med., (2021), 8, (747511), 10.3389/fcvm.2021.747511)

  • Xiaolin Zhang
  • , Minghui Cheng
  • , Naijing Gao
  • , Yi Li
  • , Chenghui Yan
  • , Xiaoxiang Tian
  • , Dan Liu
  • , Miaohan Qiu
  • , Xiaozeng Wang
  • , Bo Luan
  • , Jie Deng
  • , Shouli Wang
  • , Hongyan Tian
  • , Geng Wang
  • , Xinliang Ma
  • , Gregg W. Stone
  • , Yaling Han

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the original article, the Funding statement is incorrect. The authors neglected to include the funder “National Key Research and Development Program of China, 2016YFC1301303” for author YH and the funder “Liaoning Provincial Natural Science Foundation of China, 2019-ZD-1060” for author XZ. The corrected Funding statement appears below: “This work was supported by grants from the National Key Research and Development project of China [grant number 2016YFC1301300]. YH received funding from the National Key Research and Development Program of China, 2016YFC1301303. XZ received funding from the Liaoning Provincial Natural Science Foundation of China, 2019-ZD-1060. The funders of the study had no role in study design, data collection, analysis, interpretation, or writing of the report. The authors had access to the data and vouch for the integrity, accuracy, and completeness of the data and analyses, and for the fidelity of the study to the protocol.” In the original article, an error was made in the Abstract, section Design, Setting, and Participants. The original sentence was incorrectly written as: “An independent cohort of 398 patients enrolled at three different hospitals served as a validation cohort.” The correct sentence is: “An independent cohort of 243 patients enrolled at three different hospitals served as a validation cohort.” In the original article, an error was made in theMethods, section Study Design and Participants. The original sentence was incorrectly written as: “A second patient group, serving as a validation cohort, comprised 398 patients with the same inclusion and exclusion criteria presenting to the emergency department of three different hospitals (eAppendix 1) between May 2016, and November 2016”. The correct sentence is: “A second patient group, serving as a validation cohort, comprised 243 patients with the same inclusion and exclusion criteria presenting to the emergency department of three different hospitals (eAppendix 1) between May 2016 and November 2016.” The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number840102
JournalFrontiers in Cardiovascular Medicine
Volume9
DOIs
StatePublished - 23 Feb 2022
Externally publishedYes

Keywords

  • S100A12
  • ST-segment elevation myocardial infarction
  • cardiovascular disease(s)
  • diagnosis
  • prognosis

Fingerprint

Dive into the research topics of 'Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction(Front. Cardiovasc. Med., (2021), 8, (747511), 10.3389/fcvm.2021.747511)'. Together they form a unique fingerprint.

Cite this